Results 121 to 130 of about 3,956,965 (389)

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

THE HISTORY OF MEDICINE IN CANADA [PDF]

open access: yesMedical History, 1968
A paper read at the Symposium on the History of Medicine in the Commonwealth, organized by the Faculty of the History of Medicine and Pharmacy, and held at the Royal College of Physicians of London on 23 September 1966.
openaire   +2 more sources

Propagation & brief history of Tibetan Medicine [PDF]

open access: yes, 2004
この論文は国立情報学研究所の学術雑誌公開支援事業により電子化されまし
Dawa
core   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Polyarchion (πολυάρχιον) in the medicine of Antiquity and Byzantium [PDF]

open access: yesFarmacja Polska
The present research is devoted to the history of a medicine used in the Ancient and Byzantine Mediterranean, known in the local medical tradition as polyarchion (πολυάρχιον).
Maciej Kokoszko   +3 more
doaj   +1 more source

The Development of Sports Medicine in Twentieth-century Britain [PDF]

open access: yes, 2009
Annotated and edited transcript of a Witness Seminar held on 29 June 2007. Introduction by Dr John Lloyd Parry, Institute of Sports and Exercise Medicine. First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2009. ©The Trustee
Reynolds, LA, Tansey, EM
core  

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

open access: yesMolecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy